Aviva’s Probitas buy to bolster non-life margins through 2024

Shares in London-listed Aviva were muted in early trading on Monday despite positive analysts commentary after the UK insurer surprised the market with news it would once again build a presence in Lloyd’s through the £242mn acquisition of Probitas.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com